Bumper Offer - Urjas oil Just @ Rs. 1
Niftas is a prescription drug, available for use as Tablet. It is primarily used for the treatment of Urinary Tract Infection. The alternative uses of Niftas have also been explained below.
The correct dosage of Niftas depends on the patient's age, gender, and medical history. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
Some other side effects of Niftas have been listed ahead. These side effects of Niftas are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Niftas has a Safe effect for pregnant women and Moderate effect on lactating mothers. It is important to know if Niftas has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Niftas related warnings section.
Niftas is not recommended if you suffer from certain medical conditions as it can have adverse effects. Kidney Disease, Anemia, Liver Disease are examples of such conditions. The section on Niftas contraindications lists all such conditions.
Besides this, Niftas may also have severe interaction with some medicines. See below for a complete list.
In addition to these precautions, you may also note that Niftas is not safe while driving, and is is not addictive in nature.
Niftas is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Niftas is used -
Severe
Moderate
Mild
Is the use of Niftas safe for pregnant women?
Pregnant women can take Niftas without worrying about any side effects.
Is the use of Niftas safe during breastfeeding?
Breastfeeding women may feel side effects of Niftas. If you see any side effects, stop taking Niftas immediately and talk to your doctor. Take Niftas again, only after your doctor's advice.
What is the effect of Niftas on the Kidneys?
Niftas may have mild side effects on the kidneys.
What is the effect of Niftas on the Liver?
Niftas may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Niftas on the Heart?
Niftas may have mild side effects on the heart. Most people will never see any effect on the heart.
Niftas should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Niftas unless your doctor advises you to do so -
Is this Niftas habit forming or addictive?
Forming a habit of Niftas has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Niftas as you may feel sleepy.
Is it safe?
Niftas is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, Niftas is not used to treat mental disorders.
Interaction between Food and Niftas
Taking Niftas with food does not cause any problems.
Interaction between Alcohol and Niftas
Consuming limited amounts of alcohol while taking Niftas does not cause any harmful effects. But it is best to observe caution.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Macrobid ® (nitrofurantoin monohydrate/macrocrystals)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 760
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 914-915
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Macrobid ® (nitrofurantoin monohydrate/macrocrystals)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 760
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 914-915
